HELWAN UNIVERSITY
🇪🇬Egypt
- Country
- 🇪🇬Egypt
- Ownership
- Private
- Established
- 1975-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.helwan.edu.eg
The Effect of PRP on Wound Healing in High Risk Patients Undergoing Abdominal Hysterectomy
Phase 2
Not yet recruiting
- Conditions
- Wound HealAbdominal WoundPRP
- Interventions
- Biological: Platelets Rich plasma of the same patient
- First Posted Date
- 2024-03-07
- Last Posted Date
- 2024-03-08
- Lead Sponsor
- Helwan University
- Target Recruit Count
- 80
- Registration Number
- NCT06298110
Efficacy of Phentolamine in Prevention of Contrast-Associated Acute Kidney Injury After Complex PCI
Phase 2
Recruiting
- Conditions
- CA-AKI - Contrast-Associated Acute Kidney InjuryCoronary Artery DiseaseAcute Coronary SyndromeAdrenergic Receptor Antagonist Adverse Reaction
- Interventions
- First Posted Date
- 2024-02-29
- Last Posted Date
- 2024-03-18
- Lead Sponsor
- Helwan University
- Target Recruit Count
- 60
- Registration Number
- NCT06286059
- Locations
- 🇪🇬
Badr university hospital, Badr, Cairo, Egypt
Dexmedetomidine Versus Fentanyl on Postoperative Analgesic Profile in Laparoscopic Sleeve Gastrectomy
Not Applicable
Completed
- Conditions
- Pain, Postoperative
- Interventions
- First Posted Date
- 2024-01-02
- Last Posted Date
- 2024-01-02
- Lead Sponsor
- Helwan University
- Target Recruit Count
- 64
- Registration Number
- NCT06186895
- Locations
- 🇪🇬
Ryad Ghoraba, Tanta, Gharbia, Egypt
Drug Nephrotoxicity Amelioration by N-acetylcysteine
- First Posted Date
- 2023-11-08
- Last Posted Date
- 2024-07-05
- Lead Sponsor
- Helwan University
- Target Recruit Count
- 100
- Registration Number
- NCT06122311
- Locations
- 🇪🇬
Helwan University, Cairo, Egypt
The Impact of Oral Vitamin C in Prevention for Post Operative Atrial Fibrillation (POAF) in Coronary Artery Bypass Surgery (CABG) Patients
Phase 4
Active, not recruiting
- Conditions
- Post Operative Atrial Fibrillation
- Interventions
- Drug: Vitamin C 500 MG Oral Capsule(Low-dose 1g daily)Drug: placebo capsulesDrug: Vitamin C 500 MG Oral Capsule(High dose 2g daily)
- First Posted Date
- 2023-10-10
- Last Posted Date
- 2023-10-10
- Lead Sponsor
- Helwan University
- Target Recruit Count
- 180
- Registration Number
- NCT06074367
- Locations
- 🇪🇬
El Sheik Zayed Specialized Hospital, Giza, Egypt
Role of NFKBIA and PTPN22 Genes Polymorphism in Acute Rejection Susceptibility After Living Donor Liver Transplantation in Egyptian Patients.
Completed
- Conditions
- Liver Transplant Rejection
- First Posted Date
- 2023-09-29
- Last Posted Date
- 2023-09-29
- Lead Sponsor
- Helwan University
- Target Recruit Count
- 105
- Registration Number
- NCT06060808
- Locations
- 🇪🇬
Sara Mohamed Mohamed, Cairo, Egypt
Dexmedetomidine vs Fentanyl on Time to Extubation in Patients Undergoing Laparoscopic Sleeve Gastrectomy
Not Applicable
Completed
- Conditions
- DexmedetomidineFentanylMorbid ObesityTime to ExtubationLaparoscopic Sleeve Gastrectomy
- Interventions
- Drug: Group F (fentanyl group)Drug: Group D (dexmedetomidine group)
- First Posted Date
- 2023-09-25
- Last Posted Date
- 2023-09-25
- Lead Sponsor
- Helwan University
- Target Recruit Count
- 64
- Registration Number
- NCT06052111
- Locations
- 🇪🇬
Helwan University, Helwan, Cairo, Egypt
Intrathecal Injection of Hyperbaric Bupivacaine Versus a Mixture of Hyperbaric and Isobaric Bupivacaine in Patients Undergoing Lower Abdominal Surgery
Not Applicable
Completed
- Conditions
- Lower Abdominal SurgerySpinal AnesthesiaHyperbaric BupivacaineIsobaric Bupivacaine
- Interventions
- Drug: Group A (hyperbaric bupivacaine)Drug: Group B (Mixture of Hyperbaric and Isobaric Bupivacaine)
- First Posted Date
- 2023-09-22
- Last Posted Date
- 2023-09-22
- Lead Sponsor
- Helwan University
- Target Recruit Count
- 50
- Registration Number
- NCT06050044
- Locations
- 🇪🇬
Helwan University, Helwan, Cairo, Egypt
A Comparative Study Between Concomitant Versus Load Therapy in Eradication of Helicobacter Pylori Infection
Phase 4
Completed
- Conditions
- H. Pylori Infection
- Interventions
- Drug: Comparing Load and Concomitant therapy
- First Posted Date
- 2023-09-22
- Last Posted Date
- 2023-09-26
- Lead Sponsor
- Helwan University
- Target Recruit Count
- 200
- Registration Number
- NCT06050824
- Locations
- 🇪🇬
Faculty of Medicine, Helwan University, Cairo, Egypt
Long Term Follow up of Water Vapor Thermal Therapy (Rezum) for Benign Prostatic Hyperplasia (BPH)
Not Applicable
Active, not recruiting
- Conditions
- Benign Prostatic Hyperplasia
- Interventions
- Procedure: water vapor thermal therapy (Rezum) for prostate
- First Posted Date
- 2023-08-08
- Last Posted Date
- 2023-08-08
- Lead Sponsor
- Helwan University
- Target Recruit Count
- 50
- Registration Number
- NCT05982444
- Locations
- 🇪🇬
Faculty of Medicine Helwan University, Helwan, Cairo, Egypt
© Copyright 2025. All Rights Reserved by MedPath